Auxilius Pharma
United States
- Boston, Massachusetts
- 14/06/2023
- Seed
- $1,000,000
Pharma start-up with a focus on optimizing and further developing well-established medications
- Industry Pharmaceutical Manufacturing
- Website https://www.auxiliuspharma.com/
- LinkedIn https://www.linkedin.com/company/auxilius-pharma/
Related People
Jedrzej Litwiniuk, MHAFounder
United States -
Boston, Massachusetts
CEO at Auxilius Pharma, a value added generic start-up. Healthcare Strategy and Corporate Finance Consultant and Executive. M&A and Investment Professional. Co-founder and Advisory Board Member at Picket Pharmaceuticals, Inc.
Experienced executive with extensive operational and corporate finance knowledge of the healthcare industry. Since 2018 focusing on developing pharmaceutical start-up companies.
Previously I have gained my expertise as outpatient chain M&A manager, venture capital and asset management Investment Director complemented with two years experience as CEO of orthopedics and spine surgery inpatient clinic in Warsaw, Poland and co-founder and CFO of Picket Pharmaceuticals, Inc, New York based complex generic start-up company. CEMS Master diploma holder (equivalent of MBA run by top European Schools of Business). Executive Master of Health Administration at Columbia University, NY.
Syntracts | $5,300,000 | (Oct 24, 2025)
GradBridge | $20,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
CipherOwl | $15,000,000 | (Oct 24, 2025)
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
Vermeer | $10,000,000 | (Oct 24, 2025)
GammaTime | $14,000,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Apriority Financial, Inc. | $2,300,000 | (Oct 24, 2025)
OneAM | $4,700,000 | (Oct 24, 2025)
🌱 Rightcharge | $2,131,920 | (Oct 24, 2025)
Tensormesh | $4,500,000 | (Oct 24, 2025)